A detailed history of Frontier Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Frontier Asset Management, LLC holds 31,938 shares of ABT stock, worth $3.76 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares
31,938
Previous 31,938 -0.0%
Holding current value
$3.76 Million
Previous $3.63 Million 8.6%
% of portfolio
1.31%
Previous 1.45%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$100.78 - $112.29 $34,466 - $38,403
-342 Reduced 1.06%
31,938 $3.48 Million
Q1 2023

May 10, 2023

SELL
$96.86 - $114.01 $121,075 - $142,512
-1,250 Reduced 3.73%
32,280 $3.27 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $3.19 Million - $3.74 Million
33,530 New
33,530 $3.68 Million
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $3.69 Million - $4.52 Million
31,938 New
31,938 $4.5 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Frontier Asset Management, LLC Portfolio

Follow Frontier Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Asset Management, LLC with notifications on news.